Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer

Immunomodulator-targeting therapies are under development in gastric cancer (GC). However, the role of genes modulating anti-tumor immunity in GC remains poorly understood. We investigated the association of variations in genes involved in immunomodulatory pathways with overall survival (OS) in loco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacogenomics J
Autors principals: Sunakawa, Y, Cao, S, Volz, NB, Berger, MD, Yang, D, Parekh, A, Zhang, W, Matsusaka, S, Ning, Y, Stremitzer, S, Stintzing, S, Sebio, A, Okazaki, S, Wakatsuki, T, Azuma, M, Watanabe, M, Koizumi, W, Wu, AH, Lenz, H-J
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507965/
https://ncbi.nlm.nih.gov/pubmed/27241062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2016.46
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars